Mary-Lee Dequeant
Research Subjects
Mary-Lee Dequeant has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Sacher
Princess Margaret Cancer Centre 7 Toronto, ON
42 shared publications - Alissa Keegan
CRISPR Therapeutics, Boston, Massachusetts. 11
42 shared publications - Anna Ma
CRISPR Therapeutics, Boston, Massachusetts. 11
42 shared publications - Ben Tran
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
42 shared publications - Changan Guo
Formerly employed by CRISPR Therapeutics, Boston, Massachusetts. 12
42 shared publications - Ellen B. Gurary
Formerly employed by CRISPR Therapeutics, Boston, Massachusetts. 12
42 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
COBALT-RCC trial design schematic
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
COBALT-RCC trial design schematic
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
CONSORT flow diagram for COBALT-RCC trial design schematic
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
CONSORT flow diagram for COBALT-RCC trial design schematic
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Cytokine secretion during CAR T-cell activation upon coculture with CD70+ RCC cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Cytokine secretion during CAR T-cell activation upon coculture with CD70+ RCC cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Summary of Treatment-Related TEAEs in Safety Analysis Set by Dose Level
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Summary of Treatment-Related TEAEs in Safety Analysis Set by Dose Level
- Open Access
- 31 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Cytokine secretion during CAR T-cell activation upon coculture with CD70+ RCC cells
- 31 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Cytokine secretion during CAR T-cell activation upon coculture with CD70+ RCC cells